Exela Competitors

Delisted . USA . 
Stock . Exela Technologies
XELADelisted Stock  USD 1.11  0.01  0.89%   
Exela Technologies competes with HeartCore Enterprises, Infobird, Quhuo, CXApp, and Beamr Imaging; as well as few others. The company conducts business under IT Services sector and is part of Information Technology industry. Analyzing Exela Technologies competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Exela Technologies to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Exela Technologies competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.061.117.37
Details
Intrinsic
Valuation
LowRealHigh
0.051.057.31
Details
Naive
Forecast
LowNextHigh
0.010.726.98
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.701.532.37
Details

Exela Technologies Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Exela Technologies and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Exela and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Exela Technologies does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
SOUN
+ 0.82
HTCR
QH
+ 0.67
MVLA
IDAI
+ 0.58
IFBD
MVLA
+ 0.52
HTCR
BMR
+ 0.5
CXAI
QH
+ 0.49
HTCR
  
High negative correlations   
CXAI
- 0.71
MVLA
CXAI
- 0.7
QH
CXAI
- 0.66
HTCR
BMR
- 0.64
HTCR
SOUN
- 0.59
BMR
BMR
- 0.44
MVLA

Risk-Adjusted Indicators

There is a big difference between Exela Pink Sheet performing well and Exela Technologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Exela Technologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Exela Technologies Competitive Analysis

The better you understand Exela Technologies competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Exela Technologies' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Exela Technologies' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
XELA HTCR KBNT MVLA IFBD QH CXAI BMR SOUN IDAI
 0.89 
 1.11 
Exela
 3.68 
 1.69 
HeartCore
 1.72 
 0.57 
Kubient
 1.06 
 1.87 
Movella
 25.00 
 3.30 
Infobird
 6.87 
 1.40 
Quhuo
 5.03 
 1.67 
CXApp
 7.21 
 3.27 
Beamr
 18.15 
 9.31 
SoundHound
 17.86 
 0.69 
Trust
Market Volatility
(90 Days Market Risk)
Abnormally volatile
Dangerous
Very steady
Very steady
Risky
Out of control
Very risky
Unstable
Relatively risky
Abnormally volatile
Market Performance
(90 Days Performance)
Very Weak
Solid
Very Weak
Very Weak
Good
OK
Very Weak
Very Weak
Solid
OK
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Low
Dangerous
Dangerous
Low
Below Average
Very High
Low
Low
High
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Over Valued
Over Valued
Under Valued
Under Valued
Under Valued
Under Valued
Over Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Sell
Not Available
Not Available
Strong Buy
Buy
Buy
Strong Buy
Strong Buy
Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Not Rated
Not Rated
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
0.36
3.22
12.89
N/A
1.66
1.32
N/A
0.36
1.11
3.15
Net Asset
636.34 M
19.62 M
15.23 M
106.93 M
57.66 M
1.03 B
36.58 M
11.52 M
151.12 M
7.89 M
Profit Margin
-0.0973
-0.49
N/A
-0.45
N/A
-0.011
N/A
-0.64
-1.64
-1.74
EBITDA
80.18 M
(4.16 M)
(10.75 M)
(15.26 M)
(2.57 M)
35.71 M
(53.58 M)
(425 K)
(65.14 M)
(7.63 M)
Operating Margin
-0.0109
-0.37
-211.6
-0.93
-8.22
-0.0315
-1.75
-1.55
-1.4
-5.25
Current Valuation
1.09 B
31.02 M
(10.28 M)
5.74 M
2.43 M
127.47 M
29.55 M
33.46 M
3.35 B
17.19 M
Price To Book
N/A
2.85
0.75
0.0378
0.11
1.94
1.93
2.29
11.63
2.95
Retained Earnings
(2.08 B)
(14.76 M)
(40.2 M)
(142.02 M)
(24.6 M)
(1.38 B)
(57.8 M)
(31.67 M)
(592.38 M)
(50.85 M)
Current Asset
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Five Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Beta
1.89
1.49
2.68
0.48
1.18
0.59
0.88
0.74
3.04
-0.74
Number Of Employees
13.1 K
99
16
241
11
490
N/A
28
260
83
Shares Outstanding
6.37 M
20.93 M
14.73 M
50.91 M
1.99 M
89.07 M
16.46 M
15.51 M
337.02 M
23.15 M
Cash Flow From Operations
3.56 M
(4.33 M)
(9.6 M)
(14.55 M)
(2.72 M)
(97.28 M)
(17.91 M)
(659 K)
(68.27 M)
(7.85 M)
Annual Yield
N/A
0.0567
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Debt
1.11 B
4.89 M
78.9 K
31.98 M
63 K
105.53 M
3.56 M
500 K
90.16 M
1.09 M
Return On Equity
N/A
-1.11
-0.76
-0.26
-0.67
-0.0715
-1.39
-0.12
-0.68
-3.73
Z Score
N/A
N/A
6.35
-1.99
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.0038
-0.19
-0.3
-0.1
-0.0447
-0.0361
-0.17
-0.0515
-0.18
-0.72
Number Of Shares Shorted
780.22 K
109.1 K
39.3 K
240.13 K
44.65 K
38.39 K
1.1 M
440.59 K
86.36 M
109.93 K
Book Value Per Share
-141.99
0.25
0.72
1.4
42.88
45.57
0.89
1.43
0.8
0.41
Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Asset
636.34 M
19.62 M
15.23 M
106.93 M
57.66 M
1.03 B
36.58 M
11.52 M
151.12 M
7.89 M
Short Ratio
14.3
0.27
1.0
0.25
1.13
0.35
2.38
2.86
2.46
0.11
Target Price
2.0
2.75
1.5
3.75
N/A
29.34
5.0
8.0
8.07
0.75
Debt To Equity
N/A
0.53
0.004
N/A
0.31
0.24
N/A
0.98
N/A
0.23
Shares Owned By Institutions
6.86
0.85
19.59
42.85
0.014
0.05
6.7
0.87
29.25
8.4
Market Capitalization
6.87 M
35.38 M
1.47 M
2.69 M
6.56 M
125.57 M
27.49 M
50.72 M
3.14 B
19.44 M
Price To Earning
-0.01
222.73
N/A
N/A
N/A
N/A
N/A
23.19
N/A
N/A
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
0.0067
2.07
3.96
0.0675
23.42
0.035
3.82
17.16
46.62
4.12
Net Income
(125.16 M)
(4.19 M)
(13.62 M)
(33.05 M)
(2.58 M)
3.33 M
(53.62 M)
(695 K)
(88.94 M)
(7.64 M)
Earnings Per Share
-16.63
0.23
-0.87
2.9
-53.73
-0.55
2.01
-0.11
-0.35
-0.85
Shares Owned By Insiders
N/A
75.1
25.23
18.03
0.09
0.16
46.05
31.1
2.23
33.45
Revenue
1.06 B
21.85 M
2.4 M
40.47 M
280 K
3.7 B
7.37 M
2.91 M
45.87 M
4.56 M
Working Capital
(213.67 M)
(1.02 M)
12.87 M
(8.15 M)
5.4 M
240.64 M
(1.29 M)
5.82 M
89.32 M
(1.57 M)
Cash And Equivalents
10.4 M
12.46 M
17.68 M
N/A
13.39 M
147.96 M
N/A
46.66 M
33.41 M
2.83 M
Cash Per Share
0.09
0.7
1.23
N/A
2.63
31.59
N/A
0.24
0.17
0.12
Gross Profit
277.51 M
5.19 M
2.74 M
19.17 M
1.98 M
252.69 M
N/A
N/A
21.53 M
2.53 M
Day Typical Price
1.09
1.67
0.59
1.9
2.99
1.39
1.64
3.18
8.92
0.68
Accumulation Distribution
0.11
0.0751
0.0806
0.0558
0.28
0.0426
0.1
0.0795
0.17
0.19
Market Facilitation Index
0.13
0.13
0.05
0.11
0.93
0.06
0.18
0.26
1.62
0.14
Daily Balance Of Power
(0.08)
0.4615
(0.20)
(0.18)
0.7097
1.5
0.4444
0.8462
0.8827
(1.07)
Period Momentum Indicator
(0.01)
0.06
(0.01)
(0.02)
0.66
0.09
0.08
0.22
1.43
(0.15)
Rate Of Daily Change
0.99
1.04
0.98
0.99
1.25
1.07
1.05
1.07
1.18
0.82
Day Median Price
1.09
1.67
0.6
1.92
2.84
1.38
1.63
3.14
8.72
0.68
Price Action Indicator
0.02
0.055
(0.03)
(0.06)
0.79
0.065
0.08
0.24
1.31
(0.07)
Relative Strength Index
43.46
50.3
55.79
33.81
55.46
40.54
74.54
40.84
80.04
39.57
Coefficient Of Variation
(813.46)
397.18
106376.02
1106.99
737.19
769.49
(2,048)
4779.26
530.58
886.18
Mean Deviation
2.71
5.41
4.26
3.96
4.53
11.34
3.35
3.3
4.28
8.65
Jensen Alpha
(0.68)
1.26
(0.29)
0.7062
1.08
5.36
(0.48)
(0.13)
0.8089
2.57
Total Risk Alpha
(1.69)
0.5647
(1.33)
(0.50)
(0.26)
(1.41)
(1.00)
(0.65)
0.1245
(1.17)
Sortino Ratio
N/A
0.2334
(0.02)
0.104
0.1827
0.6668
N/A
(0.01)
0.2363
0.2206
Downside Variance
N/A
45.12
46.47
17.71
25.66
51.74
N/A
10.59
19.33
106.7
Standard Deviation
5.8
6.77
7.98
6.37
7.84
37.97
4.6
4.36
6.24
21.41
Kurtosis
39.91
(0.44)
21.78
15.41
15.6
60.99
2.94
1.52
3.42
25.39
Potential Upside
5.12
14.14
7.94
8.82
11.0
14.56
7.01
8.63
18.15
9.09
Treynor Ratio
1.95
0.4935
(0)
(0.51)
(5.33)
(1.43)
(0.12)
0.0486
0.416
(1.90)
Maximum Drawdown
48.72
26.35
59.23
44.13
25.02
329.09
29.23
24.22
39.21
47.05
Variance
33.69
45.87
63.65
40.56
61.43
1441.5
21.2
19.02
38.99
458.59
Market Risk Adjusted Performance
1.96
0.5035
0.0089
(0.50)
(5.32)
(1.42)
(0.11)
0.0586
0.426
(1.89)
Risk Adjusted Performance
(0.09)
0.2013
0.0098
0.0779
0.1127
0.1091
(0.03)
0.0242
0.1529
0.0959
Skewness
(5.59)
(0.01)
3.42
3.09
3.18
7.66
(0.64)
0.9992
1.02
4.81
Semi Deviation
N/A
5.44
5.26
3.5
4.12
5.14
N/A
3.16
3.75
6.48
Information Ratio
(0.15)
0.2315
(0.02)
0.0687
0.1181
0.1263
(0.08)
(0.01)
0.1664
0.1064
Value At Risk
(5.07)
(10.17)
(9.80)
(5.77)
(7.55)
(8.21)
(7.25)
(5.02)
(6.75)
(11.11)
Expected Short fall
N/A
(6.38)
(6.12)
(5.06)
(5.68)
(15.97)
N/A
(4.63)
(5.79)
(19.21)
Downside Deviation
N/A
6.72
6.82
4.21
5.07
7.19
N/A
3.25
4.4
10.33
Semi Variance
N/A
29.62
27.66
12.27
16.99
26.41
N/A
9.98
14.1
41.99

Exela Technologies Competition Performance Charts

Five steps to successful analysis of Exela Technologies Competition

Exela Technologies' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Exela Technologies in relation to its competition. Exela Technologies' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Exela Technologies in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Exela Technologies' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Exela Technologies, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Exela Technologies position

In addition to having Exela Technologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Drugs Thematic Idea Now

Drugs
Drugs Theme
Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. The Drugs theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Drugs Theme or any other thematic opportunities.
View All  Next Launch
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Consideration for investing in Exela Pink Sheet

If you are still planning to invest in Exela Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exela Technologies' history and understand the potential risks before investing.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Transaction History
View history of all your transactions and understand their impact on performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY